5VE-25019-36432
5 vaccinations
5 coded responses
40 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 775 / TX
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
57C-22457-04595
Child or adolescent in my care · Female · 2022-06-28
DNZ-14331-92548
Child or adolescent in my care · Female · 2023-03-22
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-27
- 2020-12-28
- 2020-12-29
-
2020-12-31
Health check-in — day 7, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-31
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
-
2021-01-20
Survey response — day 7, dose 2MedDRA: Cough, Respiratory tract congestion — Feeling: GoodFree text: Congestion and mild coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-04-14
- 2021-07-14
-
2021-10-12
Dose 3 — Pfizer-BioNTech
-
2022-01-13
Survey response — 12 months, dose 2MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion — Feeling: GoodFree text: Have had a cold for about two weeks: sore throat, cough, and congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-06-07
Dose 4 — Pfizer-BioNTech
- 2022-06-14
- 2022-06-21
- 2022-06-28
- 2022-07-05
- 2022-07-13
- 2022-07-19
-
2022-10-07
Dose 5 — Pfizer-BioNTech
- 2022-10-08
-
2022-10-09
Survey response — days 1–6 daily, dose 5MedDRA: Pre-existing disease — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Ongoing pre-existing coldMedDRA releases: 2024-11 · check-in free text available
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-21
-
2022-10-28
Survey response — day 21, dose 5MedDRA: Headache — Feeling: GoodFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-11-04
-
2022-11-13
Survey response — day 35, dose 5MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-11-21
- 2023-01-07
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
| 4 | 2022-06-07 | Pfizer-BioNTech | No |
| 5 | 2022-10-07 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-31 | priority 2/3 |
Free text
Release 2 — day 7, dose 2
Systemic reaction (other): Congestion and mild cough
Release 10 — 12 months, dose 2
Symptoms: Have had a cold for about two weeks: sore throat, cough, and congestion
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Ongoing pre-existing cold
Release 12 — day 21, dose 5
Symptoms: Headache
Release 12 — day 35, dose 5
Symptoms: Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release